RESUMO
OBJECTIVE: A 24-hour day is made up of time spent in a range of physical activity (PA) behaviours, including sleep, sedentary time, standing, light-intensity PA (LIPA) and moderate-to-vigorous PA (MVPA), all of which may have the potential to alter an individual's health through various different pathways and mechanisms. This study aimed to explore the relationship between PA behaviours and the gut microbiome in older adults. DESIGN: Cross-sectional study. SETTINGS AND PARTICIPANTS: Participants (n=100; age 69.0 [3.0] years; 44% female) from the Mitchelstown Cohort Rescreen (MCR) Study (2015-2017). METHODS: Participants provided measures of gut microbiome composition (profiled by sequencing 16S rRNA gene amplicons), and objective measures of PA behaviours (by a 7-day wear protocol using an activPAL3 Micro). RESULTS: Standing time was positively correlated with the abundance of butyrate-producing and anti-inflammatory bacteria, including Ruminococcaceae, Lachnospiraceae and Bifidobacterium, MVPA was positively associated with the abundance of Lachnospiraceae bacteria, while sedentary time was associated with lower abundance of Ruminococcaceae and higher abundance of Streptococcus spp. CONCLUSION: Physical activity behaviours appear to influence gut microbiota composition in older adults, with different PA behaviours having diverging effects on gut microbiota composition.
Assuntos
Envelhecimento/fisiologia , Exercício Físico , Microbioma Gastrointestinal , Idoso , Estudos Transversais , Feminino , Humanos , Irlanda , Masculino , Pessoa de Meia-Idade , RNA Ribossômico 16S , Comportamento SedentárioRESUMO
Aims Our aim was to assess if outcomes for cystic fibrosis (CF) patients at six & sixteen years of age have improved in the last 17 years looking at FEV1, BMI and death. Methods A retrospective observational study using a prospectively maintained database of CF patients at Cork University Hospital. Results 84 patients were included in the 16-year-old data and 89 patients were included in the six-year-old data. The mean FEV1 and BMI (16 years) for the 2002-2007 group was 72.9±21.0% and 18.9±2.53 respectively, 2008-2013 group was 75.4±27.2% and 19.8±2.7 and for the 2014-2018 group was 95.2±16.0% and 22.9±4.1. The percentage of patients (16 years) with chronic pseudomonas status was 37.9% (11/30) in the 2002-2007 group, 51.6 % (16/31) in the 2008-2013 group and 4.2% (1/24) in the 2014-2018 group. The relationship between FEV1 and FVC with BMI remained significant in multivariate analysis (P <0.001). The mean FEV1 (six years) for the 2002-2007 group was 90.7±16.1%, 2008-2013 group was 99.3±17.9% and for the 2014-2018 group was 100.9±15.8%. Conclusions Improvements in FEV1 and BMI aged six and 16 years are notable as well as a significant decline in the number of patients with chronic pseudomonas.
RESUMO
AIMS: Cannabidiol (CBD) is a cannabis-derived medicinal product with potential application in a wide-variety of contexts; however, its effective dose in different disease states remains unclear. This review aimed to investigate what doses have been applied in clinical populations, in order to understand the active range of CBD in a variety of medical contexts. METHODS: Publications involving administration of CBD alone were collected by searching PubMed, EMBASE and ClinicalTrials.gov. RESULTS: A total of 1038 articles were retrieved, of which 35 studies met inclusion criteria covering 13 medical contexts. Twenty-three studies reported a significant improvement in primary outcomes (e.g. psychotic symptoms, anxiety, seizures), with doses ranging between <1 and 50 mg/kg/d. Plasma concentrations were not provided in any publication. CBD was reported as well tolerated and epilepsy was the most frequently studied medical condition, with all 11 studies demonstrating positive effects of CBD on reducing seizure frequency or severity (average 15 mg/kg/d within randomised controlled trials). There was no signal of positive activity of CBD in small randomised controlled trials (range n = 6-62) assessing diabetes, Crohn's disease, ocular hypertension, fatty liver disease or chronic pain. However, low doses (average 2.4 mg/kg/d) were used in these studies. CONCLUSION: This review highlights that CBD has a potential wide range of activity in several pathologies. Pharmacokinetic studies as well as conclusive phase III trials to elucidate effective plasma concentrations within medical contexts are severely lacking and highly encouraged.
Assuntos
Canabidiol/administração & dosagem , Ansiedade/sangue , Ansiedade/diagnóstico , Ansiedade/tratamento farmacológico , Canabidiol/farmacocinética , Ensaios Clínicos Fase III como Assunto , Relação Dose-Resposta a Droga , Humanos , Transtornos Psicóticos/sangue , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/tratamento farmacológico , Ensaios Clínicos Controlados Aleatórios como Assunto , Convulsões/sangue , Convulsões/diagnóstico , Convulsões/tratamento farmacológico , Índice de Gravidade de Doença , Resultado do TratamentoAssuntos
Antropometria/métodos , Pavilhão Auricular , Estética/psicologia , Fotografação , Atitude do Pessoal de Saúde , Pavilhão Auricular/anormalidades , Pavilhão Auricular/diagnóstico por imagem , Pavilhão Auricular/cirurgia , Pesquisas sobre Atenção à Saúde , Humanos , Cirurgia Plástica/métodos , Cirurgia Plástica/psicologiaAssuntos
Pescoço/patologia , Osteossarcoma/patologia , Neoplasias Cutâneas/patologia , Idoso , Humanos , MasculinoRESUMO
In 2004 a large focus of Plasmodium knowlesi malaria was reported in the human population in Sarawak, Malaysian Borneo. Plasmodium knowlesi, a parasite of the South-East Asian macaques (Macaca fascicularis and Macaca nemestrina), had entered the human population. Plasmodium knowlesi is transmitted by the leucosphyrus group of Anopheline mosquitoes and transmission is largely zoonotic and restricted to the jungle setting. Humans entering jungle transmission sites are at risk. Since 2004, human cases of P. knowlesi have been continuously reported in local communities and in travellers returning from South East Asia. Plasmodium knowlesi is the most common type of indigenous malaria reported in Malaysia. Infections are most often uncomplicated but at least 10% of patients report with severe malaria and 1-2% of cases have a fatal outcome. Parasitaemia is positively associated with the clinical and laboratory markers of severe malaria. The current literature on P. knowlesi, including epidemiology, natural hosts and vectors, pathogenesis, clinical descriptions, treatment and diagnosis, is reviewed. There are many gaps in our understanding of this disease that are highlighted here with suggestions for further research to inform pre-emptive control measures that would be required to prevent a full emergence of this parasite into the human population.
Assuntos
Malária/epidemiologia , Malária/parasitologia , Plasmodium knowlesi/isolamento & purificação , Zoonoses/epidemiologia , Zoonoses/parasitologia , Animais , Anopheles/parasitologia , Antimaláricos/uso terapêutico , Sudeste Asiático/epidemiologia , Reservatórios de Doenças , Humanos , Insetos Vetores , Macaca/parasitologia , Malária/diagnóstico , Malária/transmissão , Resultado do Tratamento , Zoonoses/diagnóstico , Zoonoses/transmissãoRESUMO
BACKGROUND: This paper describes the development of a complex intervention to promote mental wellbeing using the revised framework for developing and evaluating complex interventions produced by the UK Medical Research Council (UKMRC). METHODS: Application of the first two phases of the framework is described--development and feasibility and piloting. The theoretical case and evidence base were examined analytically to explicate the theoretical and empirical foundations of the intervention. These findings informed the design of a 12-week mental wellbeing promotion programme providing early intervention for people showing signs of mental health difficulties. The programme is based on the theoretical constructs of self-efficacy, self-esteem, purpose in life, resilience and social support and comprises 10 steps. A mixed methods approach was used to conduct a feasibility study with community and voluntary sector service users and in primary care. RESULTS: A significant increase in mental wellbeing was observed following participation in the intervention. Qualitative data corroborated this finding and suggested that the intervention was feasible to deliver and acceptable to participants, facilitators and health professionals. CONCLUSIONS: The revised UKMRC framework can be successfully applied to the development of public health interventions.
Assuntos
Promoção da Saúde/métodos , Saúde Mental , Modelos Teóricos , Medicina Baseada em Evidências , Feminino , Pesquisa sobre Serviços de Saúde , Humanos , Masculino , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Escalas de Graduação Psiquiátrica , Reino UnidoRESUMO
BACKGROUND: Reduction in pulmonary exacerbations is an important efficacy endpoint for CF clinical studies. Powering exacerbation endpoints requires estimation of the future exacerbation incidence in CF study populations, but rates differ across the population. METHODS: We have estimated exacerbation rates for Epidemiologic Study of CF subpopulations stratified by age, FEV(1)% predicted, sex, weight-for-age percentile, respiratory signs and symptoms, and history of exacerbation and bacterial culture. Sample sizes required to attain 80% power to detect exacerbation reductions of 20% to 80% in 1:1 randomized studies of 3 to 12 month duration were determined. Exacerbation treatments with "any" antibiotic (new oral quinolone, new inhaled antibiotic, or intravenous (IV) antibiotic) and with IV antibiotics were studied. RESULTS: At all ages, decreased FEV(1), female sex, exacerbation history, and Pseudomonas aeruginosa culture history were associated with increased treatment for exacerbation. CONCLUSIONS: These data should assist investigators in the design of future CF exacerbation studies.
Assuntos
Ensaios Clínicos como Assunto/estatística & dados numéricos , Fibrose Cística/fisiopatologia , Volume Expiratório Forçado , Pulmão/fisiopatologia , Projetos de Pesquisa/estatística & dados numéricos , Adolescente , Adulto , Criança , Fibrose Cística/terapia , Progressão da Doença , Feminino , Humanos , Masculino , Tamanho da Amostra , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Rate of lung function decline (RLFD) (as FEV(1) percent predicted/yr) is a robust measure of CF therapeutic efficacy rarely used as a study endpoint, in part due to uncertainty of sample size requirements. METHODS: Sample size requirements for 1:1 randomizations to detect RLFD treatment effects from 20% to 80% were assessed in Epidemiologic Study of CF (ESCF) patients. Effects of measuring FEV(1) 1-4 times per year in studies of 1- to 4-year durations were assessed in 399 patients age ≥ 6 years with FEV(1) ≥ 70%. Impacts of inclusion/exclusion based on risk factors in 2369 ESCF patients were assessed over 1.5 years using semi-annual FEV(1) measures. RESULTS: Increasing study duration and exclusion of lower risk patients (e.g., no P. aeruginosa infection) both substantially reduced requirements. CONCLUSIONS: CF RLFD studies of 1.5 years in duration appear feasible provided that investigators account for the beneficial effects of subject inclusion/exclusion based on risk factors in power estimates.
Assuntos
Fibrose Cística/tratamento farmacológico , Fibrose Cística/fisiopatologia , Volume Expiratório Forçado , Projetos de Pesquisa , Adolescente , Adulto , Criança , Estudos de Viabilidade , Humanos , Pulmão/fisiopatologia , Pessoa de Meia-Idade , Seleção de Pessoal , Medição de Risco , Fatores de Risco , Tamanho da Amostra , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
beta-Catenin signaling is required for embryonic tooth morphogenesis and promotes continuous tooth development when activated in embryos. To determine whether activation of this pathway in the adult oral cavity could promote tooth development, we induced mutation of epithelial beta-catenin to a stabilized form in adult mice. This caused increased proliferation of the incisor tooth cervical loop, outpouching of incisor epithelium, abnormal morphology of the epithelial-mesenchymal junction, and enhanced expression of genes associated with embryonic tooth development. Ectopic dental-like structures were formed from the incisor region following implantation into immunodeficient mice. Thus, forced activation of beta-catenin signaling can initiate an embryonic-like program of tooth development in adult rodent incisor teeth.
Assuntos
Células-Tronco Adultas/fisiologia , Papila Dentária/citologia , Órgão do Esmalte/citologia , Odontogênese/genética , beta Catenina/fisiologia , Animais , Células Epiteliais/citologia , Feminino , Fator 8 de Crescimento de Fibroblasto/biossíntese , Fator 8 de Crescimento de Fibroblasto/genética , Incisivo/citologia , Células-Tronco Mesenquimais/fisiologia , Camundongos , Camundongos Nus , Isoformas de Proteínas/biossíntese , Isoformas de Proteínas/genética , Transdução de Sinais , Calcificação de Dente , Regulação para CimaRESUMO
The Wnt/beta-catenin signaling pathway is one of several key conserved intercellular signaling pathways in animals, and plays fundamental roles in the proliferation, regeneration, differentiation, and function of many cell and tissue types. This pathway is activated in a dynamic manner during the morphogenesis of oral organs, including teeth, taste papillae, and taste buds, and is essential for these processes to occur normally. Conversely, forced activation of Wnt/beta-catenin signaling promotes the formation of ectopic teeth and taste papillae. In this review, we discuss our current understanding of the roles of Wnt/beta-catenin signaling in oral tissue development and in related human diseases, and the potential of manipulating this pathway for therapeutic purposes.
Assuntos
Desenvolvimento Maxilofacial/genética , Boca/embriologia , Odontogênese/genética , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Animais , Anormalidades Craniofaciais/embriologia , Anormalidades Craniofaciais/genética , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Desenvolvimento Maxilofacial/fisiologia , Neoplasias Bucais/embriologia , Neoplasias Bucais/genética , Odontogênese/fisiologia , Transdução de Sinais , Proteínas Wnt/genética , beta Catenina/genéticaRESUMO
Epithelial stem cells in the bulge region within the hair follicle maintain the cyclic hair growth, but whether these stem cells also contribute to the epidermal renewal remains unclear. Here, we observed that the conditional deletion of the Rac1 gene in the mouse skin, including the potential follicular and epidermal stem cell compartments, results in alopecia owing to defective hair development. Surprisingly, mice lacking the expression of this Rho GTPase do not display major alterations in the interfollicular skin. Furthermore, Rac1 excision from primary epithelial keratinocytes results in the inability to reconstitute hair follicles and sebaceous glands when grafted onto mice, but epithelial cells lacking Rac1 can nonetheless form a healthy epidermis. Together, these findings support the emerging view that the epidermis and the hair follicles are maintained by different epithelial stem cells, and provide evidence that the requirement for Rac1 function can distinguish these distinct stem cells populations.
Assuntos
Epiderme/fisiologia , Folículo Piloso/citologia , Queratinócitos/fisiologia , Neuropeptídeos/fisiologia , Regeneração , Células-Tronco/fisiologia , Proteínas rac de Ligação ao GTP/fisiologia , Animais , Movimento Celular/genética , Células Epidérmicas , Epiderme/enzimologia , Células Epiteliais/enzimologia , Células Epiteliais/fisiologia , Deleção de Genes , Folículo Piloso/anormalidades , Folículo Piloso/crescimento & desenvolvimento , Queratinócitos/enzimologia , Camundongos , Camundongos Mutantes , Neuropeptídeos/antagonistas & inibidores , Neuropeptídeos/genética , Regeneração/genética , Células-Tronco/enzimologia , Proteínas rac de Ligação ao GTP/antagonistas & inibidores , Proteínas rac de Ligação ao GTP/genética , Proteínas rac1 de Ligação ao GTPRESUMO
We report two cases of Caesarean section in patients with Marfan's syndrome where continuous subarachnoid anaesthesia failed to provide an adequate surgical block. This was possibly because of dural ectasia, which was confirmed by a computed tomography scan in both cases.
Assuntos
Anestesia Obstétrica/métodos , Raquianestesia , Dura-Máter/patologia , Síndrome de Marfan/metabolismo , Adulto , Anestésicos Locais/farmacocinética , Cesárea , Dilatação Patológica/diagnóstico por imagem , Dilatação Patológica/metabolismo , Dura-Máter/diagnóstico por imagem , Feminino , Humanos , Síndrome de Marfan/diagnóstico por imagem , Gravidez , Tomografia Computadorizada por Raios XRESUMO
Intercellular signaling is essential for the development of teeth during embryogenesis and in maintenance of the continuously growing incisor teeth in postnatal rodents. WNT intercellular signaling molecules have been implicated in the regulation of tooth development, and the Wnt3 gene shows specific expression in the enamel knot at the cap stage. We demonstrate here that Wnt3 also is expressed in specific epithelial cell layers in postnatal incisor teeth. To begin to delineate the functions of Wnt3 in developing and postnatal teeth, we determined the effects of over- and ectopic expression of Wnt3 in the tooth epithelium of mice carrying a keratin 14-Wnt3 transgene. Expression of the transgene caused a progressive loss of ameloblasts from postnatal lower incisor teeth. Loss of ameloblasts may be due to defective proliferation or differentiation of ameloblast precursors, progressive apoptosis of ameloblasts, or loss of ameloblast stem cells.
Assuntos
Ameloblastos/metabolismo , Incisivo/crescimento & desenvolvimento , Proteínas Proto-Oncogênicas/metabolismo , Ameloblastos/patologia , Animais , Calcificação Fisiológica/fisiologia , Regulação da Expressão Gênica no Desenvolvimento , Hibridização In Situ , Incisivo/anormalidades , Proteínas de Filamentos Intermediários/genética , Proteínas de Filamentos Intermediários/metabolismo , Queratinas Específicas do Cabelo , Camundongos , Camundongos Transgênicos , Proteínas Proto-Oncogênicas/genética , Células-Tronco/metabolismo , Células-Tronco/patologia , Anormalidades Dentárias/genética , Proteínas Wnt , Proteína Wnt-5aAssuntos
Doenças dos Peixes/epidemiologia , Doenças dos Peixes/virologia , Linguado , Orthoreovirus/isolamento & purificação , Infecções por Reoviridae/veterinária , Criação de Animais Domésticos , Animais , Doenças dos Peixes/patologia , Hepatite Viral Animal/epidemiologia , Hepatite Viral Animal/virologia , Fígado/patologia , Fígado/ultraestrutura , Microscopia Eletrônica/veterinária , Orthoreovirus/ultraestrutura , Infecções por Reoviridae/epidemiologia , Infecções por Reoviridae/virologia , Escócia/epidemiologiaAssuntos
Testes de Química Clínica/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Preparações Farmacêuticas/metabolismo , Valores de Referência , Analgésicos/efeitos adversos , Analgésicos/metabolismo , Antiarrítmicos/efeitos adversos , Antiarrítmicos/metabolismo , Antibacterianos/efeitos adversos , Antibacterianos/metabolismo , Anticonvulsivantes/efeitos adversos , Anticonvulsivantes/metabolismo , Antidepressivos/efeitos adversos , Antidepressivos/metabolismo , HumanosRESUMO
Mutations in WNT effector genes perturb hair follicle morphogenesis, suggesting key roles for WNT proteins in this process. We show that expression of Wnts 10b and 10a is upregulated in placodes at the onset of follicle morphogenesis and in postnatal hair follicles beginning a new cycle of hair growth. The expression of additional Wnt genes is observed in follicles at later stages of differentiation. Among these, we find that Wnt5a is expressed in the developing dermal condensate of wild type but not Sonic hedgehog (Shh)-null embryos, indicating that Wnt5a is a target of SHH in hair follicle morphogenesis. These results identify candidates for several key follicular signals and suggest that WNT and SHH signaling pathways interact to regulate hair follicle morphogenesis.
Assuntos
Folículo Piloso/metabolismo , Proteínas do Tecido Nervoso , Proteínas Proto-Oncogênicas/genética , Transativadores/genética , Animais , Indução Embrionária , Perfilação da Expressão Gênica , Regulação da Expressão Gênica no Desenvolvimento , Folículo Piloso/citologia , Folículo Piloso/embriologia , Folículo Piloso/crescimento & desenvolvimento , Proteínas Hedgehog , Hibridização In Situ , Camundongos , Morfogênese , Mutação , Proteínas Proto-Oncogênicas/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais , Pele/embriologia , Pele/metabolismo , Transativadores/metabolismo , Regulação para Cima , Proteínas Wnt , Proteína Wnt-5aRESUMO
Perioperative levels of jugular bulb oxyhaemoglobin saturation (Sj(O(2))) and lactate concentration (Lj), and postoperative duration of Sj(O(2))<50% were compared between patients undergoing coronary artery bypass grafting (CABG) (n=86), heart valve (n=14) and abdominal aortic (n=16) surgery. Radial artery and jugular bulb blood samples were aspirated after induction of anaesthesia, during re-warming on cardiopulmonary bypass (CPB) (36 degrees C), on arrival in the intensive care unit (ICU) and, subsequently, at 1, 2 and 6 h after ICU admission. Most patients having heart surgery were hypocapnic at 36 degrees C on CPB. Following CABG and heart valve surgery, many patients were hypocapnic whereas after abdominal aortic surgery, most were hypercapnic. During CPB and postoperatively, Sj(O(2)) and Lj were significantly correlated to Pa(CO(2)) and the arterial concentration of lactate (La) respectively (P<0.05). After correction for arterial carbon dioxide tension (Pa(CO(2))) and La, there were no significant changes in Sj(O(2)) or Lj on CPB. Postoperatively, having corrected for Pa(CO(2)), there were significant effects on Sj(O(2)) over all groups as a result of time from surgery (P<0.001) and its interaction with operation type (P<0.001). Following correction for La, there were no postoperative effects on Lj. No significant differences (P=0.2) in duration of Sj(O(2))<50% existed between patients undergoing CABG (1054 (82) min), abdominal aortic (893 (113) min) and heart valve (1073 (91) min) surgery. The lack of significant reciprocal effects on Lj combined with the frequency of hypocapnia and strong influence of Pa(CO(2))()on Sj(O(2)), suggest that Sj(O(2))<50% during CPB and after cardiac surgery represents hypoperfusion as a consequence of hypocapnia rather than cerebral ischaemia.
Assuntos
Isquemia Encefálica/etiologia , Procedimentos Cirúrgicos Cardiovasculares/efeitos adversos , Idoso , Anestesia Geral , Aorta Abdominal/cirurgia , Dióxido de Carbono/sangue , Ponte Cardiopulmonar , Ponte de Artéria Coronária/efeitos adversos , Feminino , Valvas Cardíacas/cirurgia , Humanos , Ácido Láctico/sangue , Masculino , Pessoa de Meia-Idade , Oxigênio/sangue , Oxiemoglobinas/metabolismo , Pressão ParcialRESUMO
Many patients believe that the education they receive about their health and their illnesses is inadequate or lacking. Nurse executives are in a key position to influence their patients' abilities to become more informed and to take greater responsibility for their healthcare decisions. In the article, the authors discuss Massachusetts General Hospital's state-of-the-art consumer health information library, including how the project was planned, organized, and implemented.
Assuntos
Bibliotecas Hospitalares/organização & administração , Educação de Pacientes como Assunto , Desenvolvimento de Programas/métodos , Boston , Comportamento do Consumidor , Arquitetura de Instituições de Saúde , Humanos , Serviços de Informação , Sistemas de Informação , Equipes de Administração Institucional , Marketing de Serviços de Saúde , Design de SoftwareRESUMO
Most common forms of hair loss (alopecia) are caused by aberrant hair follicle cycling and changes in hair follicle morphology. However, current treatments for alopecia do not specifically target these processes. We are now beginning to identify the molecules and molecular pathways that control normal hair follicle formation, cycling and growth. In parallel, new techniques are being developed for delivering molecules to hair follicles. Here, we outline the characteristics of common hair loss diseases, and discuss ways in which recent advances in hair follicle biology could be translated into effective therapies for these conditions.